B. Krämer

No ORCID on file · 13 papers in corpus · active 2018-2026

Study types

  • article 8
  • dataset 2
  • other 2
  • case-report 1

Condition tags

  • endometriosis 2
  • die_deep_infiltrating 1
article 2026
Additional file 1 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723643

Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.

article 2026
Additional file 1 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723643.v1

Supplementary Material 1: Table S1. Table S1 – Annotation of the abbreviations used by the IVDr lipoprotein profiling analysis.

dataset 2026
Additional file 2 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723646

Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.

dataset 2026
Additional file 2 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723646.v1

Supplementary Material 2: Tables S2-S3. Table S2 – Assay-specific lower limits of quantitation (LLOQ, pg/mL) used to define missing cytokine values. Table S3 – Membership of non-grey WGCNA modules identified in the signed network analysis.

article 2026
Additional file 4 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723652.v1

Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.

article 2026
Additional file 4 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723652

Supplementary Material 4: Table S4A. Table S4A – Exploratory nominal cytokine-metabolite and cytokine-lipoprotein associations (Spearman raw p < 0.05) in the endometriosis-only and sensitivity cohorts.

article 2026
Additional file 5 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723655

Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.

article 2026
Additional file 5 of NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.32723655.v1

Supplementary Material 5: Table S4B. Table S4B – FDR-significant cytokine-cytokine correlations in the endometriosis-only and sensitivity cohorts.

other 2026
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.c.8544015.v1

Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…

other 2026
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.6084/m9.figshare.c.8544015

Abstract Background Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy control…

article 2026
NMR-based serum metabolite and lipoprotein profiling for endometriosis across clinically relevant and physiological comparator settings: assessment of diagnostic utility and exploratory biological signals
·doi:10.1186/s12916-026-04999-2

BACKGROUND: Reliable non-invasive biomarkers for endometriosis remain unavailable in routine practice, and their translational value depends on performance in symptomatic referral populations rather than only against healthy controls. We ev…

case-report 2022
Acute endometriosis-related sigmoid perforation in pregnancy- case report
BMC pregnancy and childbirth ·doi:10.1186/s12884-022-04973-9

BACKGROUND: An acute abdomen is an emergency that requires accurate diagnosis and prompt treatment. In pregnancy, the process is even more challenging and sometimes the radiological findings are unclear. Moreover, endometriosis- related com…

article 2018
Iatrogenic endometriosis harbors somatic cancer-driver mutations
Human Reproduction ·doi:10.1093/humrep/dey332

STUDY QUESTION: Does incisional endometriosis (IE) harbor somatic cancer-driver mutations? SUMMARY ANSWER: We found that approximately one-quarter of IE cases harbor somatic-cancer mutations, which commonly affect components of the MAPK/RAS…